Global CI Leader Deallus is a long‑standing life science competitive intelligence partner with deep pharma, biotech, and med‑tech relationships, making it a strong entry point for global pharma accounts needing actionable market dynamics, portfolio strategy, pricing, and R&D insights.

Therapy Focus Depth Specialization in neuroscience, oncology, rare diseases, and vaccines enables targeted outreach to clinical development, market access, and strategy teams seeking domain‑driven insights to inform decision making.

Lifecycle Solutions The broad service mix across market insights, market access, value and pricing, R&D, portfolio strategy, medical affairs, and brand marketing supports cross‑functional selling as a single vendor for end‑to‑end needs.

Embedded Collaboration A peer‑to‑peer, extension‑of‑client‑teams delivery model with workshop and forecasting capabilities positions Deallus as a collaborative CI partner that integrates with internal teams and accelerates decision cycles.

Acquisition Context Recent acquisition activity in the life sciences CI space signals consolidation, presenting opportunities to position as an integration partner for larger platforms or as a flexible CI addon within merged client ecosystems.